HYDROXYPROPYL BETADEX is an organic molecular entity. It is under investigation in clinical trial NCT03471143 (Study of IV VTS-270 for Infantile Liver Disease Associated With Niemann-Pick Disease, Type C). The directory classifies it as a commercial API with a semi-synthetic source/manufacturing origin. Other names for this substance include Hydroxypropyl bcd and HPBCD. Its PubChem CID is 138059664.
Hydroxypropyl betadex
| CAS No | 128446-35-5 |
|---|---|
| Molecular Formula | C60H106O40 |
| Molecular Weight | 1467.5 g/mol |
| Synonyms | (1S,3R,5R,6S,8R,10R,11S,13R,15R,16S,18S,20R,21S,23R,25R,26R,28R,30R,31S,33R,35R,36R,37R,38R,39R,40R,41R,42R,43R,45R,46S,47R,48S,49R)-5,10,25,35-tetrakis(hydroxymethyl)-40,47,49-tris(2-hydroxypropoxy)-15,20,30-tris(2-hydroxypropoxymethyl)-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo[31.2.2.23,6.28,11.213,16.218,21.223,26.228,31]nonatetracontane-36,37,38,39,41,42,43,45,46,48-decol |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
HYDROXYPROPYL BETADEX is an organic molecular entity. It is under investigation in clinical trial NCT03471143 (Study of IV VTS-270 for Infantile Liver Disease Associated With Niemann-Pick Disease, Type C).
The listed CAS number is 128446-35-5.
The listed molecular formula is C60H106O40.
The listed molecular weight is 1467.5 g/mol.
(1S,3R,5R,6S,8R,10R,11S,13R,15R,16S,18S,20R,21S,23R,25R,26R,28R,30R,31S,33R,35R,36R,37R,38R,39R,40R,41R,42R,43R,45R,46S,47R,48S,49R)-5,10,25,35-tetrakis(hydroxymethyl)-40,47,49-tris(2-hydroxypropoxy)-15,20,30-tris(2-hydroxypropoxymethyl)-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo[31.2.2.23,6.28,11.213,16.218,21.223,26.228,31]nonatetracontane-36,37,38,39,41,42,43,45,46,48-decol.
The source lists Hydroxypropyl bcd and HPBCD.